Finasteride
THIS MEDICINE IS FOR USE IN MEN ONLY.
Finapil is a film-coated tablet containing the active substance finasteride. Finasteride inhibits the activity of 5α-reductase type II, an enzyme involved in the metabolism of testosterone. In men with androgenetic alopecia, finasteride reduces the concentration in the body of the product of testosterone metabolism, which contributes to male pattern hair loss (androgenetic alopecia). The medicine slows down the process of miniaturization of hair follicles on the head, leading to a reversal of the hair loss process. The best treatment results are achieved in men with mild to moderate hair loss. Finasteride does not show efficacy in the treatment of androgenetic alopecia in women.
Finapil is indicated for the treatment of male pattern hair loss (androgenetic alopecia). It is used in men to increase hair growth and prevent further hair loss. The medicine can only be used in men. The medicine is not intended for use in women, children, and adolescents.
Benign prostatic hyperplasia.
Before starting to take Finapil, discuss it with your doctor or pharmacist. Mood changes and depression. Patients taking Finapil have reported mood changes, such as depressive mood and depression, and less frequently, suicidal thoughts. If any of these symptoms occur, you should stop taking Finapil and immediately consult a doctor for further medical advice.
You should inform your doctor about taking Finapil if you are going to have a blood test to measure the level of prostate-specific antigen (PSA). Before evaluating the PSA test results, your doctor should consider doubling the PSA level in men taking Finapil.
See section 4.
Finapil should not be used in children and adolescents. There are no data on the efficacy or safety of finasteride in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all the medicines you are taking or have recently taken, as well as any medicines you plan to take.
Pregnancy. Finapil is contraindicated in women. The use of Finapil is contraindicated in women who are or may be pregnant. Handling damaged or crushed tablets can lead to the absorption of the medicine through the skin and cause developmental disorders in male fetuses. Women who are or may be pregnant, as well as women of childbearing age, should not handle crushed or damaged Finapil tablets. The tablets of Finapil are film-coated, which prevents direct contact with the medicine, provided that the tablets are not damaged or crushed. Breastfeeding. Finapil is contraindicated in women. The use of Finapil is contraindicated during breastfeeding. Fertility. There are no data on the effect on fertility in humans. Cases of infertility have been reported in men taking finasteride for a long time, who had other risk factors for fertility. However, no studies have been conducted on the effect of finasteride on fertility in men.
There are no data indicating that Finapil affects the ability to drive or use machines.
If you have been diagnosed with an intolerance to some sugars, you should consult your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be taken exactly as directed by your doctor. If you are unsure, consult your doctor or pharmacist. The recommended dose is 1 mg (1 tablet) once a day. The medicine should be taken orally with or without food. It is important to take Finapil for as long as your doctor recommends, as the medicine only works after a longer period. To increase hair growth and prevent further hair loss, it is necessary to take the medicine every day for at least 3 months. To maintain the treatment results, it is recommended to continue taking the medicine without interruption. Stopping the medicine leads to a loss of its effect within 9 to 12 months.
In case of taking more tablets than recommended, you should immediately consult a doctor.
Do not take a double dose to make up for a missed dose. If you have any further questions about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Finapil can cause side effects, although not everybody gets them. The side effects associated with taking Finapil may include decreased interest in sex and difficulty achieving an erection. You should stop taking Finapil and immediately consult a doctor if you experience any of the following symptoms (angioedema): swelling of the face, lips, tongue, or throat; difficulty swallowing; hives; and difficulty breathing. You should immediately inform your doctor about any changes in breast tissue, such as lumps, pain, enlargement of the breast, or discharge from the nipples, as these may be symptoms of a serious disease, such as breast cancer. Uncommon(may affect up to 1 in 100 people)
Frequency Not Known(frequency cannot be estimated from the available data)
If you experience an allergic reaction, you should stop taking the medicine and immediately consult a doctor.
If you experience any side effects, including any not listed in this leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. There are no special precautions for storage. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Core: lactose monohydrate, microcrystalline cellulose, maize starch, sodium carboxymethyl cellulose type A, lauryl macrogolglycerides, magnesium stearate. Coating: hypromellose 6cp, titanium dioxide (E 171), macrogol 6000, iron oxide red (E 172), iron oxide yellow (E 172).
Finapil is a reddish-brown, round, biconvex film-coated tablet. The medicine is available in PVC/Aluminum or Aluminum/Aluminum blisters in a cardboard box containing 28 or 98 film-coated tablets. Not all pack sizes may be marketed.
SUN-FARM Sp. z o.o., ul. Dolna 21, 05-092 Łomianki, tel. +48 22 350 66 69.
mibe GmbH Arzneimittel, Münchener Strasse 15, 06796 Brehna, Germany.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.